Penumbra Inc PEN

Healthcare Medical Devices

Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.

NYSE:PEN - Post by User

Penumbra Inc

<< Previous

Bullboard Posts

Post by AwareInvestoron Jan 16, 2021 9:53am

102 Views

Post# 32313021

Pacemakers: Penumbra Is Out Of The Blocks Quickly In 2021

Embattled medical devices company Penumbra Inc. was quietly having an impressive 2021, market wise, before it got loud about it Monday, releasing aggressive revenue guidance ahead of its yet-to-be-scheduled Q4 earnings call. The company then followed up with a tour-de-force performance at the JP Morgan Healthcare Conference, where the sell side hosts were all too happy to ask CEO Adam Elsesser some more “great questions,” and give the executive room to do the only thing he really needs to do right now: control the narrative.

https://thedeepdive.ca/pacemakers-penumbra-is-out-of-the-blocks-quickly-in-2021/

<< Previous

Bullboard Posts

As AI expands, where can investors look for strong growth?